1. Home
  2. PXS vs GANX Comparison

PXS vs GANX Comparison

Compare PXS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pyxis Tankers Inc.

PXS

Pyxis Tankers Inc.

HOLD

Current Price

$4.89

Market Cap

57.2M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

SELL

Current Price

$0.98

Market Cap

52.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PXS
GANX
Founded
2015
2017
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.2M
52.2M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PXS
GANX
Price
$4.89
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $6.60
AVG Volume (30 Days)
78.5K
★ 718.3K
Earning Date
11-30-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
★ N/A
N/A
Revenue
N/A
★ $55,180.00
Revenue This Year
$19.84
N/A
Revenue Next Year
$2.03
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.67
$0.94
52 Week High
$8.34
$4.34

Technical Indicators

Market Signals
Indicator
PXS
GANX
Relative Strength Index (RSI) 26.14 39.17
Support Level $3.98 $0.94
Resistance Level $8.32 $1.91
Average True Range (ATR) 0.44 0.13
MACD -0.10 0.02
Stochastic Oscillator 10.89 16.64

Price Performance

Historical Comparison
PXS
GANX

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: